{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:09:17Z","timestamp":1789132157090,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA038789"],"award-info":[{"award-number":["K23DA038789"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.contraception.2018.08.008","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T12:53:28Z","timestamp":1534164808000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder"],"prefix":"10.1016","volume":"99","author":[{"given":"Anupama","family":"Kotha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P.","family":"Himes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Krans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2018.08.008_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"Heil","year":"2011","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.contraception.2018.08.008_bb0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008-2011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2018.08.008_bb0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1479-828X.2012.01413.x","article-title":"Unplanned pregnancy and contraceptive use in women attending drug treatment services","volume":"52","author":"Black","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","article-title":"Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review","volume":"80","author":"Terplan","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.contraception.2018.08.008_bb0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/GRF.0000000000000098","article-title":"Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations","volume":"58","author":"Krans","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2017.12.023","article-title":"Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder","volume":"185","author":"Krans","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.contraception.2018.08.008_bb0035","doi-asserted-by":"crossref","first-page":"47.e1","DOI":"10.1016\/j.ajog.2017.02.040","article-title":"Racial and ethnic disparities in postpartum care and contraception in California's Medicaid program","volume":"217","author":"Thiel de Bocanegra","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/08897077.2015.1118720","article-title":"Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: a retrospective cohort study","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.contraception.2018.08.008_bb0045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.contraception.2018.08.008_bb0050","series-title":"Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.contraception.2018.08.008_bb0055","first-page":"e251-e69","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.contraception.2017.07.167","article-title":"Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder","volume":"96","author":"Matusiewicz","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.08.008_bb0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.contraception.2005.05.016","article-title":"Barriers to intrauterine device insertion in postpartum women","volume":"72","author":"Ogburn","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.08.008_bb0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00404-006-0287-z","article-title":"Effect of postpartum counseling on postpartum contraceptive use","volume":"275","author":"Engin-Ustun","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2018.08.008_bb0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/AOG.0b013e3181f73fac","article-title":"Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial","volume":"116","author":"Chen","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0080","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/AOG.0000000000002633","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2018.04.016","article-title":"Predictors for follow-up among postpartum patients enrolled in a clinical trial","author":"Baldwin","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.08.008_bb0090","series-title":"Opioid use disorders in pregnancy: Management guidelines for improving outcomes","first-page":"113","article-title":"Postpartum care for women with substance use disorders","author":"Krans","year":"2018"},{"key":"10.1016\/j.contraception.2018.08.008_bb0095","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/AOG.0000000000001587","article-title":"Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception","volume":"128","author":"American College of Obstetrics and Gynecologists","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00192-005-1293-6","article-title":"Effects of pregnancy and childbirth on postpartum sexual function: a longitudinal prospective study","volume":"16","author":"Connolly","year":"2005","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.contraception.2018.08.008_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/AOG.0000000000001798","article-title":"Implementing immediate postpartum long-acting reversible contraception programs","volume":"129","author":"Hofler","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2018.08.008_bb0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.contraception.2016.06.018","article-title":"Home or office etonogestrel implant insertion after pregnancy: a randomized trial","volume":"94","author":"Uhm","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.08.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.03.023","article-title":"Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting","volume":"211","author":"Schauberger","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.08.008_bb0125","article-title":"The pregnancy recovery center: a women-centered treatment program for pregnant and postpartum women with opioid use disorder","volume":"24","author":"Krans","year":"2018","journal-title":"Addict Behav"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418304013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418304013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:13:45Z","timestamp":1757880825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782418304013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0010782418304013"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2018.08.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2018.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}